$93.1M
$38,000
0.0% of portfolio
38,913
Q4 2025
Added 161.16%
$16.1B
$2.73 Million
0.0% of portfolio
50,009
Q4 2025
Reduced 4.74%
$449M
$260,000
0.0% of portfolio
8,354
Q4 2025
New
$441M
$149,000
0.0% of portfolio
2,751
Q4 2025
New
$2.21B
$1.81 Million
0.0% of portfolio
72,244
Q4 2025
Added 174.68%
$2.14B
$1.88 Million
0.0% of portfolio
50,226
Q4 2025
Added 66.55%
$1B
$253,000
0.0% of portfolio
16,781
Q4 2025
Reduced 57.21%
$5.17B
$1.82 Million
0.0% of portfolio
57,113
Q4 2025
Added 317.74%
$146M
$146,000
0.0% of portfolio
5,098
Q4 2025
New
Orchid Is Cap Inc Com New
-
$552,000
0.0% of portfolio
-
Q4 2025
New
Oruka Therapeutics Inc Com
-
$251,000
0.0% of portfolio
-
Q4 2025
New
$9.96B
$3.79 Million
0.0% of portfolio
96,687
Q4 2025
Reduced 27.06%
$20.5B
$2.75 Million
0.0% of portfolio
15,782
Q4 2025
Reduced 69.05%
$3.86B
$1.38 Million
0.0% of portfolio
14,876
Q4 2025
Reduced 8.7%
$465M
$323,000
0.0% of portfolio
18,825
Q4 2025
Reduced 58.47%
$989M
$483,000
0.0% of portfolio
12,848
Q4 2025
Reduced 15.44%
$6.07B
$3.61 Million
0.0% of portfolio
32,690
Q4 2025
Added 549.77%
$3.57B
$1.43 Million
0.0% of portfolio
24,279
Q4 2025
Added 104.97%
$1.09B
$491,000
0.0% of portfolio
18,988
Q4 2025
Added 20.93%
$727M
$662,000
0.0% of portfolio
20,949
Q4 2025
Added 23.85%
$4.67B
$1.28 Million
0.0% of portfolio
21,361
Q4 2025
Reduced 8.07%
Pennymac Corp Note 8.500 6/0
-
$925,000
0.0% of portfolio
-
Q2 2025
New
$11.3B
$640,000
0.0% of portfolio
4,045
Q4 2025
Added 34.16%
$1.3B
$732,000
0.0% of portfolio
22,874
Q4 2025
Reduced 41.27%
$2.84B
$470,000
0.0% of portfolio
23,839
Q4 2025
Reduced 0.64%
$84.2M
$15,000
0.0% of portfolio
12,261
Q4 2025
Reduced 26.94%
$895M
$331,000
0.0% of portfolio
15,145
Q4 2025
Added 74.62%
$181M
$460,000
0.0% of portfolio
86,399
Q4 2025
Added 28.96%
$1.39B
$1.2 Million
0.0% of portfolio
40,807
Q4 2025
Added 113.55%
$1.04B
$500,000
0.0% of portfolio
52,599
Q4 2025
Added 53.14%
$55.5M
$24,000
0.0% of portfolio
10,747
Q4 2025
Reduced 56.78%
$81.1M
$177,000
0.0% of portfolio
50,020
Q4 2025
New
$1.21B
$1.79 Million
0.0% of portfolio
240,556
Q4 2025
Added 4.65%
$5.7B
$2.05 Million
0.0% of portfolio
57,059
Q4 2025
Added 108.94%
-
$3.69 Million
0.0% of portfolio
-
Q4 2025
Added 44.88%
Rapid7 Inc Note 0.250 3/1
-
$1.18 Million
0.0% of portfolio
-
Q2 2024
Reduced 41.86%
Rapport Therapeutics Inc Com
-
$293,000
0.0% of portfolio
-
Q4 2025
Added 54.4%
$1.43B
$677,000
0.0% of portfolio
47,845
Q4 2025
Added 23.58%
$747M
$308,000
0.0% of portfolio
75,224
Q4 2025
Added 411.69%
$789M
$388,000
0.0% of portfolio
6,816
Q4 2025
Added 63.14%
$350M
$506,000
0.0% of portfolio
66,619
Q4 2025
Added 184.25%
$9.13B
$2.66 Million
0.0% of portfolio
18,980
Q4 2025
Added 95.53%
$5.94B
$1.33 Million
0.0% of portfolio
16,723
Q4 2025
Added 56.09%
$14.3B
$423,000
0.0% of portfolio
5,860
Q4 2025
Reduced 39.44%
$606M
$26,000
0.0% of portfolio
14,465
Q4 2025
Reduced 27.1%
$4.31B
$984,000
0.0% of portfolio
51,929
Q4 2025
Added 45.93%
$279B
$944,000
0.0% of portfolio
3,887
Q4 2025
Reduced 86.58%
$1.95B
$3.72 Million
0.0% of portfolio
84,349
Q4 2025
Added 602.44%
$700M
$353,000
0.0% of portfolio
29,091
Q4 2025
Added 44.36%
$3.14B
$816,000
0.0% of portfolio
13,985
Q4 2025
Reduced 67.0%